JANONE
JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021.
JANONE
Industry:
Biotechnology Recycling
Founded:
1983-01-01
Address:
Minneapolis, Minnesota, United States
Country:
United States
Website Url:
http://www.janone.com
Total Employee:
51+
Status:
Active
Contact:
952-930-9000
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
Agriprotein
Agriprotein specializes in nutrient recycling to create sustainable sources of protein for the mono-gastric animal feed industry.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-09-14 | GeoTraq Inc. | GeoTraq Inc. acquired by JanOne | N/A |
Official Site Inspections
http://www.janone.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.4 K
- Host name: 104.21.85.53
- IP address: 104.21.85.53
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "JanOne"
Our Company - JanOne a biotech company to treat โฆ
When we launched JanOne and entered into the world of pharmaceuticals, our aim was to ensure we remained true to maintaining businesses with social โฆSee details»
JanOne - A Biotechnology Company
JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for โฆSee details»
Company Information :: JanOne Inc. (ALTS)
JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a โฆSee details»
JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA โฆ
LAS VEGAS, July 12, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of market open on Monday, July 15, 2024, the Company's new โฆSee details»
JanOne - Crunchbase Company Profile & Funding
JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease โฆSee details»
Corporate Governance :: JanOne Inc. (ALTS)
JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a โฆSee details»
JanOne Inc. - AnnualReports.com
JanOne (NASDAQ: JAN) is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid โฆSee details»
JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA โฆ
Jul 12, 2024 --JanOne Inc., a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of market open on Monday, July 15, 2024, the Company's โฆSee details»
JanOne Company Profile - Office Locations, Competitors, Revenue โฆ
Sep 12, 2024 JanOne has 5 employees at their 1 location and $39.61 m in annual revenue in FY 2022. See insights on JanOne including office locations, competitors, revenue, financials, โฆSee details»
JanOne - Overview, News & Similar companies | ZoomInfo.com
View JanOne (www.janone.com) location in Nevada, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. โฆSee details»
Management Team :: JanOne Inc. (ALTS)
JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for โฆSee details»
JanOne - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 18, 2023: Post-IPO Equity โฆSee details»
JanOne Announces Plan to Enhance Stockholder Value Through
Jul 10, 2024 JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell Microcap Index, โฆSee details»
JanOne's Subsidiary, Alt5, Reports 91% year over year increase in ...
Jun 13, 2024 About JanOne. JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell โฆSee details»
Frequently Asked Questions - JanOne - NASDAQ-Listed Company
The companyโs name, JanOne, expresses the start of a new day and new beginnings. January One is the first day of a New Year โ a day of optimism, resolution, and hope. JanOne affirms โฆSee details»
JanOne Announces Plan to Enhance Stockholder Value Through
Jul 10, 2024 JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell Microcap Index, โฆSee details»
JanOne Announces Plan to Enhance Stockholder Value Through โฆ
Jul 10, 2024 JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell Microcap Index, โฆSee details»
Board of Directors :: JanOne Inc. (ALTS)
Richard D. Butler, Jr. has been a director of the Company since May 2015. Mr. Butler is the owner of an advisory firm that provides real estate, corporate, and financial advisory services since โฆSee details»
Tony Isaac โ CEO - JanOne
Tony Isaac โ CEO โ Mr. Isaac has been a director of the Company since May 2015 and Chief Executive Officer of the Company since May 2016. Mr. Isaac has served as Financial Planning โฆSee details»
Corporate Governance :: JanOne Inc. (JAN)
JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a โฆSee details»